Basit öğe kaydını göster

dc.contributor.authorKarakoc, B
dc.contributor.authorGerceker, AA
dc.date.accessioned2021-03-03T07:39:51Z
dc.date.available2021-03-03T07:39:51Z
dc.date.issued2001
dc.identifier.citationKarakoc B., Gerceker A., "In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, cilt.18, sa.6, ss.567-570, 2001
dc.identifier.issn0924-8579
dc.identifier.otherav_132d3119-9d0c-431a-97cd-27b4d6fd92c7
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/18346
dc.identifier.urihttps://doi.org/10.1016/s0924-8579(01)00458-7
dc.description.abstractThe in-vitro activities of various antibiotics, either alone or in combination with amikacin were assessed using clinical isolates of Pseudomonas aeruginosa. The minimum inhibitory concentrations (MIC) of these antibiotics were determined by microbroth dilution method against 50 clinical strains. The MIC values showed that 96, 94, and 74%, of the isolates were susceptible or moderately susceptible to amikacin, meropenem and ceftazidime, respectively. The in vitro activities of ceftazidime and meropenem in combination with amikacin were determined by microbroth chequerboard technique and results were interpreted using the fractional inhibitory concentration (FIC) index. With a FIC index of less than or equal to 0.5 as borderline, synergistic interactions were more frequent with ceftazidime (70.8%) than with meropenem (40%). No antagonism was observed. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
dc.language.isoeng
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectEczacılık
dc.subjectSağlık Bilimleri
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectMikrobiyoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.titleIn-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
dc.contributor.department, ,
dc.identifier.volume18
dc.identifier.issue6
dc.identifier.startpage567
dc.identifier.endpage570
dc.contributor.firstauthorID127022


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster